4//SEC Filing
Macdonald R. Loch 4
Accession 0001127602-18-021589
CIK 0001472091other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:35 PM ET
Size
5.1 KB
Accession
0001127602-18-021589
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+20,000→ 20,000 totalExercise: $1.10→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001653008
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:35 PM ET
- Size
- 5.1 KB